We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Counterfeit Medical Products Infiltrating Healthcare Markets

By HospiMedica International staff writers
Posted on 10 Feb 2010
Counterfeit medical products are becoming an international epidemic, according to the World Health Organization (WHO, Geneva, Switzerland), who claims that more than 8% of the medical devices in circulation are imitations.

In response to the growing threat of counterfeit medical products, the WHO created the International Medical Products Anti-Counterfeiting Taskforce (IMPACT, Geneva, Switzerland) to raise awareness, mobilize nations, and draft international legislation on counterfeit medical device and drugs. More...
The offending products may be assembled from inferior quality components, or even worse, from fake parts that could contain toxic materials; in either case, the dangers are the same. Counterfeit medical devices pose a significant liability to the manufacturers and a health risk to both the patients and healthcare providers that could result in injury, permanent disability, or even death.

Created in 2006, IMPACT has been active in forging international collaboration to seek global solutions to this global challenge and in raising awareness of the dangers of counterfeit medical products. Among the members are representatives of Interpol, the Organization for Economic Cooperation and Development (OECD), the World Customs Organization, the World Intellectual Property Organization, the World Trade Organization, Asociacion LatinoAmericana de Industrias Farmaceuticas, The World Bank, The European Commission, the International Council of Nurses, the World Medical Association, Pharmaciens sans frontiers, and many others.

"The potential health risks to consumers aren't the only dangers,” said Steve Delepine, vice president of business development at BrandWatch Technologies (Portland, OR, USA), a leading supplier of brand security and product authentication solutions using advanced covert technologies for in-field verification, product fingerprinting, and forensic investigation. "The effects of legal liabilities, negative branding, and revenue loss can ultimately bankrupt a company.”

In many countries, Internet-based sales are a major source of counterfeit products and drugs, threatening those who seek cheaper, stigmatized, or unauthorized treatments. Illegal Internet pharmacies and medical product suppliers conceal their real identity, operating internationally from a remote location and selling medications and devices without prescriptions, and delivering products or drugs with unknown and unpredictable origins or history.

Related Links:
World Health Organization
International Medical Products Anti-Counterfeiting Taskforce
BrandWatch Technologies


Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
IV Therapy Cart
Avalo I.V Therapy Cart
Digital Color Doppler Ultrasound System
MS22Plus
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.